Acoustic neuroma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acoustic neuroma}} | {{Acoustic neuroma}} | ||
{{CMG}}{{AE}}{{Simrat}} | {{CMG}}{{AE}}{{Simrat}} {{M.B}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of acoustic neuroma are [[neurofibromatosis type 2]] | Common [[Risk factor|risk factors]] in the development of acoustic neuroma are [[neurofibromatosis type 2]] and [[radiation]] exposure. Less common [[Risk factor|risk factors]] include sporadic defects in [[Tumor suppressor gene|tumor suppressor genes]], exposure to loud noise, history of [[parathyroid adenoma]], and the use of cellular phones. | ||
==Risk Factors== | ==Risk Factors== | ||
*Neurofibromatosis type 2<ref>{{Cite journal | === Common Risk Factors === | ||
*[[Neurofibromatosis type II|Neurofibromatosis type 2]]<ref>{{Cite journal | |||
| author = [[Michael E. Sughrue]], [[Andrea H. Yeung]], [[Martin J. Rutkowski]], [[Steven W. Cheung]] & [[Andrew T. Parsa]] | | author = [[Michael E. Sughrue]], [[Andrea H. Yeung]], [[Martin J. Rutkowski]], [[Steven W. Cheung]] & [[Andrew T. Parsa]] | ||
| title = Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics | | title = Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics | ||
| Line 29: | Line 30: | ||
| pmid = 27958595 | | pmid = 27958595 | ||
}}</ref> | }}</ref> | ||
*Childhood exposure to [[radiation]] of the [[head]] and [[neck]]<ref>{{Cite journal | |||
*Childhood exposure to [[radiation]] of the [[head]] and [[neck]] | |||
| author = [[Arthur B. Schneider]], [[Elaine Ron]], [[Jay Lubin]], [[Marilyn Stovall]], [[Eileen Shore-Freedman]], [[Jocelyn Tolentino]] & [[Barbara J. Collins]] | | author = [[Arthur B. Schneider]], [[Elaine Ron]], [[Jay Lubin]], [[Marilyn Stovall]], [[Eileen Shore-Freedman]], [[Jocelyn Tolentino]] & [[Barbara J. Collins]] | ||
| title = Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck | | title = Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck | ||
| Line 52: | Line 52: | ||
| pmid = 6850504 | | pmid = 6850504 | ||
}}</ref> | }}</ref> | ||
*Exposure to high-dose [[ionizing radiation]]<ref>{{Cite journal | |||
*Exposure to high-dose ionizing radiation | |||
| author = [[Oyebode Taiwo]], [[Deron Galusha]], [[Baylah Tessier-Sherman]], [[Sharon Kirsche]], [[Linda Cantley]], [[Martin D. Slade]], [[Mark R. Cullen]] & [[A. Michael Donoghue]] | | author = [[Oyebode Taiwo]], [[Deron Galusha]], [[Baylah Tessier-Sherman]], [[Sharon Kirsche]], [[Linda Cantley]], [[Martin D. Slade]], [[Mark R. Cullen]] & [[A. Michael Donoghue]] | ||
| title = Acoustic neuroma: potential risk factors and audiometric surveillance in the aluminium industry | | title = Acoustic neuroma: potential risk factors and audiometric surveillance in the aluminium industry | ||
| Line 75: | Line 74: | ||
| doi = 10.3349/ymj.2016.57.3.776 | | doi = 10.3349/ymj.2016.57.3.776 | ||
| pmid = 26996581 | | pmid = 26996581 | ||
}}</ref> | }}</ref> | ||
*Exposure to loud noise on a consistent basis | |||
=== Less Common Risk Factors === | |||
*Sporadic defects in [[Tumor suppressor gene|tumor suppressor genes]] in some individuals | |||
*Exposure to loud noise on a consistent basis<ref>{{Cite journal | |||
| author = [[Colin G. Edwards]], [[Judith A. Schwartzbaum]], [[Stefan Lonn]], [[Anders Ahlbom]] & [[Maria Feychting]] | | author = [[Colin G. Edwards]], [[Judith A. Schwartzbaum]], [[Stefan Lonn]], [[Anders Ahlbom]] & [[Maria Feychting]] | ||
| title = Exposure to loud noise and risk of acoustic neuroma | | title = Exposure to loud noise and risk of acoustic neuroma | ||
| Line 88: | Line 90: | ||
| pmid = 16357108 | | pmid = 16357108 | ||
}}</ref> | }}</ref> | ||
*A concomitant history of having had a [[parathyroid]] [[adenoma]] | *A concomitant history of having had a [[parathyroid]] [[adenoma]]<ref>{{Cite journal | ||
| author = [[L. Magnus Backlund]], [[Dan Grander]], [[Lena Brandt]], [[Per Hall]] & [[Anders Ekbom]] | | author = [[L. Magnus Backlund]], [[Dan Grander]], [[Lena Brandt]], [[Per Hall]] & [[Anders Ekbom]] | ||
| title = Parathyroid adenoma and primary CNS tumors | | title = Parathyroid adenoma and primary CNS tumors | ||
| Line 100: | Line 102: | ||
| pmid = 15515018 | | pmid = 15515018 | ||
}}</ref> | }}</ref> | ||
*The use of cellular phones | *The use of cellular phones<ref>{{Cite journal | ||
| author = [[Seung-Kwon Myung]], [[Woong Ju]], [[Diana D. McDonnell]], [[Yeon Ji Lee]], [[Gene Kazinets]], [[Chih-Tao Cheng]] & [[Joel M. Moskowitz]] | | author = [[Seung-Kwon Myung]], [[Woong Ju]], [[Diana D. McDonnell]], [[Yeon Ji Lee]], [[Gene Kazinets]], [[Chih-Tao Cheng]] & [[Joel M. Moskowitz]] | ||
| title = Mobile phone use and risk of tumors: a meta-analysis | | title = Mobile phone use and risk of tumors: a meta-analysis | ||
| Line 132: | Line 134: | ||
| doi = 10.1097/EDE.0b013e3182448295 | | doi = 10.1097/EDE.0b013e3182448295 | ||
| pmid = 22249239 | | pmid = 22249239 | ||
}}</ref> | }}</ref><ref name="BaanGrosse2011">{{cite journal|last1=Baan|first1=Robert|last2=Grosse|first2=Yann|last3=Lauby-Secretan|first3=Béatrice|last4=El Ghissassi|first4=Fatiha|last5=Bouvard|first5=Véronique|last6=Benbrahim-Tallaa|first6=Lamia|last7=Guha|first7=Neela|last8=Islami|first8=Farhad|last9=Galichet|first9=Laurent|last10=Straif|first10=Kurt|title=Carcinogenicity of radiofrequency electromagnetic fields|journal=The Lancet Oncology|volume=12|issue=7|year=2011|pages=624–626|issn=14702045|doi=10.1016/S1470-2045(11)70147-4}}</ref><ref>{{cite journal|title=Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case–control study|journal=Cancer Epidemiology|volume=35|issue=5|year=2011|pages=453–464|issn=18777821|doi=10.1016/j.canep.2011.05.012}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 18:08, 24 April 2019
|
Acoustic neuroma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Acoustic neuroma risk factors On the Web | |
|
American Roentgen Ray Society Images of Acoustic neuroma risk factors | |
|
Risk calculators and risk factors for Acoustic neuroma risk factors | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Mohsen Basiri M.D.
Overview
Common risk factors in the development of acoustic neuroma are neurofibromatosis type 2 and radiation exposure. Less common risk factors include sporadic defects in tumor suppressor genes, exposure to loud noise, history of parathyroid adenoma, and the use of cellular phones.
Risk Factors
Common Risk Factors
- Neurofibromatosis type 2[1][2]
- Childhood exposure to radiation of the head and neck[3][4]
- Exposure to high-dose ionizing radiation[5][6]
Less Common Risk Factors
- Sporadic defects in tumor suppressor genes in some individuals
- Exposure to loud noise on a consistent basis[7]
- A concomitant history of having had a parathyroid adenoma[8]
- The use of cellular phones[9][10][11][12][13]
References
- ↑ Michael E. Sughrue, Andrea H. Yeung, Martin J. Rutkowski, Steven W. Cheung & Andrew T. Parsa (2011). "Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics". Journal of neurosurgery. 114 (2): 359–366. doi:10.3171/2009.10.JNS091135. PMID 19943731. Unknown parameter
|month=ignored (help) - ↑ M. Ruggieri, A. D. Pratico, A. Serra, L. Maiolino, S. Cocuzza, P. Di Mauro, L. Licciardello, P. Milone, G. Privitera, G. Belfiore, M. Di Pietro, F. Di Raimondo, A. Romano, A. Chiarenza, M. Muglia, A. Polizzi & D. G. Evans (2016). "Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies". Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 36 (5): 345–367. doi:10.14639/0392-100X-1093. PMID 27958595. Unknown parameter
|month=ignored (help) - ↑ Arthur B. Schneider, Elaine Ron, Jay Lubin, Marilyn Stovall, Eileen Shore-Freedman, Jocelyn Tolentino & Barbara J. Collins (2008). "Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck". Neuro-oncology. 10 (1): 73–78. doi:10.1215/15228517-2007-047. PMID 18079359. Unknown parameter
|month=ignored (help) - ↑ E. Shore-Freedman, C. Abrahams, W. Recant & A. B. Schneider (1983). "Neurilemomas and salivary gland tumors of the head and neck following childhood irradiation". Cancer. 51 (12): 2159–2163. PMID 6850504. Unknown parameter
|month=ignored (help) - ↑ Oyebode Taiwo, Deron Galusha, Baylah Tessier-Sherman, Sharon Kirsche, Linda Cantley, Martin D. Slade, Mark R. Cullen & A. Michael Donoghue (2014). "Acoustic neuroma: potential risk factors and audiometric surveillance in the aluminium industry". Occupational and environmental medicine. 71 (9): 624–628. doi:10.1136/oemed-2014-102094. PMID 25015928. Unknown parameter
|month=ignored (help) - ↑ Mantao Chen, Zuoxu Fan, Xiujue Zheng, Fei Cao & Liang Wang (2016). "Risk Factors of Acoustic Neuroma: Systematic Review and Meta-Analysis". Yonsei medical journal. 57 (3): 776–783. doi:10.3349/ymj.2016.57.3.776. PMID 26996581. Unknown parameter
|month=ignored (help) - ↑ Colin G. Edwards, Judith A. Schwartzbaum, Stefan Lonn, Anders Ahlbom & Maria Feychting (2006). "Exposure to loud noise and risk of acoustic neuroma". American journal of epidemiology. 163 (4): 327–333. doi:10.1093/aje/kwj044. PMID 16357108. Unknown parameter
|month=ignored (help) - ↑ L. Magnus Backlund, Dan Grander, Lena Brandt, Per Hall & Anders Ekbom (2005). "Parathyroid adenoma and primary CNS tumors". International journal of cancer. 113 (6): 866–869. doi:10.1002/ijc.20743. PMID 15515018. Unknown parameter
|month=ignored (help) - ↑ Seung-Kwon Myung, Woong Ju, Diana D. McDonnell, Yeon Ji Lee, Gene Kazinets, Chih-Tao Cheng & Joel M. Moskowitz (2009). "Mobile phone use and risk of tumors: a meta-analysis". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27 (33): 5565–5572. doi:10.1200/JCO.2008.21.6366. PMID 19826127. Unknown parameter
|month=ignored (help) - ↑ M. P. Little, P. Rajaraman, R. E. Curtis, S. S. Devesa, P. D. Inskip, D. P. Check & M. S. Linet (2012). "Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States". BMJ (Clinical research ed.). 344: e1147. doi:10.1136/bmj.e1147. PMID 22403263. Unknown parameter
|month=ignored (help) - ↑ Isabelle Deltour, Anssi Auvinen, Maria Feychting, Christoffer Johansen, Lars Klaeboe, Risto Sankila & Joachim Schuz (2012). "Mobile phone use and incidence of glioma in the Nordic countries 1979-2008: consistency check". Epidemiology (Cambridge, Mass.). 23 (2): 301–307. doi:10.1097/EDE.0b013e3182448295. PMID 22249239. Unknown parameter
|month=ignored (help) - ↑ Baan, Robert; Grosse, Yann; Lauby-Secretan, Béatrice; El Ghissassi, Fatiha; Bouvard, Véronique; Benbrahim-Tallaa, Lamia; Guha, Neela; Islami, Farhad; Galichet, Laurent; Straif, Kurt (2011). "Carcinogenicity of radiofrequency electromagnetic fields". The Lancet Oncology. 12 (7): 624–626. doi:10.1016/S1470-2045(11)70147-4. ISSN 1470-2045.
- ↑ "Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case–control study". Cancer Epidemiology. 35 (5): 453–464. 2011. doi:10.1016/j.canep.2011.05.012. ISSN 1877-7821.